Background Image
Menu

Latest News

No Photo

3 February 2015

Biofortuna Ltd closes a £1.5m funding round

Biofortuna Ltd, the UK based molecular diagnostics company specialising in its proprietary freeze dried diagnostics and contract services, announces raising £1.5m in its latest funding round. The £1.5m funding was supported by all the company’s current...

Oxford BioTherapeutics Grants an Exclusive License to Boehringer Ingelheim

20 January 2015

Oxford BioTherapeutics Grants an Exclusive License to Boehringer Ingelheim

Oxford BioTherapeutics Grants an Exclusive License to Boehringer Ingelheim for Development and Commercialization of Antibody Products to an Oncology Target … OXFORD, England, January 14, 2015 /PRNewswire/ -- Oxford BioTherapeutics announces today that Boehringer Ingelheim has...

Antitope, INSERM and Baylor Institute to collaborate to produce manufacturing cell lines for two novel vaccines for HIV

13 January 2015

Antitope, INSERM and Baylor Institute to collaborate to produce manufacturing cell lines for two novel vaccines for HIV

Cambridge, UK – Antitope Limited (“Antitope”), an Abzena company (AIM: ABZA) that provides services and technologies to enable the development of better biopharmaceuticals, announces that it has extended its relationship with INSERM, the French National...

Comply Serve wins at Construction Computing Awards

3 December 2014

Comply Serve wins at Construction Computing Awards

Comply Serve is thrilled to announce that our progressive assurance software, ComplyPro, has won the Cloud Based Technology Of The Year category at the Construction Computing awards. Impressively Comply Serve was a runner up in two other categories: Infrastructure Project Of The...

OBT and Menarini announce start of first-in-human clinical study to treat acute myeloid leukemia

26 November 2014

OBT and Menarini announce start of first-in-human clinical study to treat acute myeloid leukemia

$1 Billion Oncology Alliance between Menarini Group & Oxford BioTherapeutics Initiates First-in-Human Study of Enhanced Antibody for Treatment of Acute Myeloid Leukemia … OXFORD, UK and BERLIN, GERMANY– 25 November 2014 – Oxford BioTherapeutics and Berlin Chemie...

Amanda Westwood, CEO of Silver Lining Solutions, gives small business tips in This is Money magazine

20 November 2014

Amanda Westwood, CEO of Silver Lining Solutions, gives small business tips in This is Money magazine

SMALL BUSINESS ESSENTIALS: How to bag a contract with the big boys and other secrets to landing game-changing deals - by Amanda Westwood, CEO, Silver Lining Solutions … If you're a small business, or self-employed, it might be difficult to imagine landing a contract with some of...

Abzena's CEO Dr John Burt talks to Cambridge Business about the company’s recent floatation on AIM and its unusual business model.

11 November 2014

Abzena's CEO Dr John Burt talks to Cambridge Business about the company’s recent floatation on AIM and its unusual business model.

Abzena's CEO Dr John Burt talks to Cambridge Business about the company’s recent floatation on AIM and its unusual business model. Read the full article here: http://www.cambridge-news.co.uk/Biotech-big-time-Abzena-s-riding-high/story-24099284-detail/story.html

Brandhouse wins Top Industry Design Award

23 October 2014

Brandhouse wins Top Industry Design Award

Brandhouse, part of Hangar Seven the content creation agency, has picked up two design awards at the Starpack Industry Awards, winning Gold in the 'Food and Drink Primary Packaging' and Best in Show 'Packaging Superstar', for its work on category leader Robinsons SQUASH'D. The...

Hangar Seven acquires Strategic Video Content Specialists, Media Ark

14 October 2014

Hangar Seven acquires Strategic Video Content Specialists, Media Ark

Leading content creation company, Hangar Seven, today announces the acquisition of Media Ark Limited, specialist creators of video content for retail and consumer brands. Established in 2007 by Matt Carroll, a prolific travel journalist, and Julian Hanton, an experienced TV...

Michelson Diagnostics launches new improved version of VivoSight OCT scanner with Micro-Camera to aid skin cancer diagnosis

14 October 2014

Michelson Diagnostics launches new improved version of VivoSight OCT scanner with Micro-Camera to aid skin cancer diagnosis

Orpington, UK, 8th October 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces the launch of a new improved version of its innovative VivoSight OCT scanner at the...